TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.890
+0.020 (1.07%)
Sep 4, 2025, 4:00 PM - Market closed

TScan Therapeutics Statistics

Total Valuation

TCRX has a market cap or net worth of $107.25 million. The enterprise value is -$14.09 million.

Market Cap107.25M
Enterprise Value -14.09M

Important Dates

The last earnings date was Tuesday, August 12, 2025, before market open.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

TCRX has 56.75 million shares outstanding. The number of shares has increased by 7.21% in one year.

Current Share Class 52.47M
Shares Outstanding 56.75M
Shares Change (YoY) +7.21%
Shares Change (QoQ) +0.28%
Owned by Insiders (%) 0.76%
Owned by Institutions (%) 53.46%
Float 44.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 15.41
Forward PS 14.09
PB Ratio 0.61
P/TBV Ratio 0.61
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.06, with a Debt / Equity ratio of 0.55.

Current Ratio 7.06
Quick Ratio 6.96
Debt / Equity 0.55
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -46.38

Financial Efficiency

Return on equity (ROE) is -63.33% and return on invested capital (ROIC) is -29.09%.

Return on Equity (ROE) -63.33%
Return on Assets (ROA) -26.77%
Return on Invested Capital (ROIC) -29.09%
Return on Capital Employed (ROCE) -53.97%
Revenue Per Employee $35,697
Profits Per Employee -$701,410
Employee Count195
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.94% in the last 52 weeks. The beta is 0.99, so TCRX's price volatility has been similar to the market average.

Beta (5Y) 0.99
52-Week Price Change -64.94%
50-Day Moving Average 1.74
200-Day Moving Average 2.11
Relative Strength Index (RSI) 57.85
Average Volume (20 Days) 207,968

Short Selling Information

The latest short interest is 1.85 million, so 3.27% of the outstanding shares have been sold short.

Short Interest 1.85M
Short Previous Month 1.72M
Short % of Shares Out 3.27%
Short % of Float 4.21%
Short Ratio (days to cover) 6.82

Income Statement

In the last 12 months, TCRX had revenue of $6.96 million and -$136.78 million in losses. Loss per share was -$2.41.

Revenue6.96M
Gross Profit -8.57M
Operating Income -144.24M
Pretax Income -96.80M
Net Income -136.78M
EBITDA -141.12M
EBIT -144.24M
Loss Per Share -$2.41
Full Income Statement

Balance Sheet

The company has $218.05 million in cash and $96.70 million in debt, giving a net cash position of $121.35 million or $2.14 per share.

Cash & Cash Equivalents 218.05M
Total Debt 96.70M
Net Cash 121.35M
Net Cash Per Share $2.14
Equity (Book Value) 176.71M
Book Value Per Share 3.11
Working Capital 189.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$126.18 million and capital expenditures -$5.07 million, giving a free cash flow of -$131.25 million.

Operating Cash Flow -126.18M
Capital Expenditures -5.07M
Free Cash Flow -131.25M
FCF Per Share -$2.31
Full Cash Flow Statement

Margins

Gross Margin -123.16%
Operating Margin -2,072.07%
Pretax Margin -1,964.88%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TCRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.21%
Shareholder Yield -7.21%
Earnings Yield -127.52%
FCF Yield -122.38%

Analyst Forecast

The average price target for TCRX is $9.40, which is 397.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.40
Price Target Difference 397.35%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 109.83%
EPS Growth Forecast (5Y) -21.15%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TCRX has an Altman Z-Score of -1.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.94
Piotroski F-Score 1